NM_001164749.2:c.1453G>A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001164749.2(NPAS3):c.1453G>A(p.Glu485Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000118 in 1,438,110 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001164749.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000480 AC: 1AN: 208230Hom.: 0 AF XY: 0.00000889 AC XY: 1AN XY: 112540
GnomAD4 exome AF: 0.0000118 AC: 17AN: 1438110Hom.: 0 Cov.: 34 AF XY: 0.0000168 AC XY: 12AN XY: 713096
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1453G>A (p.E485K) alteration is located in exon 12 (coding exon 12) of the NPAS3 gene. This alteration results from a G to A substitution at nucleotide position 1453, causing the glutamic acid (E) at amino acid position 485 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at